Market Place
Sourcing Support
Oncotelic advances AI-enabled robotics platform
30 Apr 2026 //
GLOBENEWSWIRE
Oncotelic Therapeutics Show Real-World Scientific Progress Impact
23 Apr 2026 //
GLOBENEWSWIRE
Oncotelic Therapeutics Showcases $249M Net Income & JV Progress
16 Apr 2026 //
GLOBENEWSWIRE
Oncotelic Boosts Compliance with AI-Driven Technology
10 Apr 2026 //
GLOBENEWSWIRE
Sapu Nano Launches Deciparticle Platform at BIO-Europe Spring
24 Mar 2026 //
GLOBENEWSWIRE
Sapu Nano To Unveil Everolimus Toxicology Data At SOT 2026
23 Mar 2026 //
GLOBENEWSWIRE
Oncotelic Aligns Key IP with Biotech Trends
18 Feb 2026 //
GLOBENEWSWIRE
Oncotelic Therapeutics & Sapu Bio Expand Global IP for OT-101
12 Feb 2026 //
GLOBENEWSWIRE
Oncotelic Enters 2026 with Strong Late-Stage Pipeline
10 Feb 2026 //
GLOBENEWSWIRE
Oncotelic Therapeutics & Brush & Key Publish Paper in IJMS
15 Dec 2025 //
GLOBENEWSWIRE
Oncotelic, Sapu Nano Unveil Deciparticle-Led Cancer Biomarker
04 Dec 2025 //
GLOBENEWSWIRE
IV Sapu003 Shows 67x Lower GI Exposure vs Oral Everolimus
03 Dec 2025 //
GLOBENEWSWIRE
Oncotelic, Sapu Nano Introduce Versatile Deciparticle
02 Dec 2025 //
GLOBENEWSWIRE
Oncotelic Expects Significant Value Increase Post JV Valuation
25 Nov 2025 //
GLOBENEWSWIRE
Oncotelic Therapeutics Emerges As Leader With Independent JV
21 Nov 2025 //
GLOBENEWSWIRE
Investors Await Valuation Signal From Biotech Pipeline Review
20 Nov 2025 //
GLOBENEWSWIRE
Oncotelic & Sapu Bio Publish Sub-15 Nm Nanoparticles Study
11 Nov 2025 //
GLOBENEWSWIRE
Oncotelic Advances Next-Gen Cancer Therapy Optimization
30 Oct 2025 //
GLOBENEWSWIRE
Sapu Nano to Present Sapu003 Data at SABCS 2025
30 Oct 2025 //
GLOBENEWSWIRE
Oncotelic Aims to Revive Underperforming Drugs for Cancer Care
28 Oct 2025 //
GLOBENEWSWIRE
Nanomedicine Tech Redefines Oncology Drug Delivery and Uptake
27 Oct 2025 //
PR NEWSWIRE
Oncotelic to Present Sapu003 Deciparticle Data at SABCS 2025
23 Oct 2025 //
GLOBENEWSWIRE
Sapu Nano Unveils First-in-Human Clinical Trial of Sapu-003
08 Oct 2025 //
GLOBENEWSWIRE
Oncotelic Therapeutics Building Breakthrough Portfolio
16 Sep 2025 //
GLOBENEWSWIRE
Innovative Therapeutics Pipeline Boosts Industry Market Growth
15 Sep 2025 //
PR NEWSWIRE
Oncotelic Celebrates 2 Years of Late-Stage Pipeline Progress
12 Sep 2025 //
GLOBENEWSWIRE
Oncotelic Publishes Study on TGFB2 in Pancreatic Cancer
25 Jun 2025 //
GLOBENEWSWIRE
Oncotelic CEO to Present "Deciparticles" at IDDST-Europe 2025
22 Apr 2025 //
GLOBENEWSWIRE
Oncotelic Therapeutics: New Research on Methylated TGFB2 and MGMT
31 Mar 2025 //
GLOBENEWSWIRE
Oncotelic Therapeutics Completes Phase 1 Trial of OT-101 and IL-2
25 Mar 2025 //
GLOBENEWSWIRE
Oncotelic partners with Medicilon for IND development platform
25 Feb 2025 //
GLOBENEWSWIRE
Oncotelic Presenting at Biopharma Nexus Conference San Diego 2024
08 May 2024 //
GLOBENEWSWIRE
Linkage of Cancer and Lupus in Gliomas Patients
25 Mar 2024 //
GLOBENEWSWIRE
Sapu and Cromos initiating P201 – A Registrational trial for OT-101
23 Aug 2023 //
GLOBENEWSWIRE
Oncotelic Initiates Clinical Trials Evaluating OT-101
25 Jan 2023 //
GLOBENEWSWIRE
